Mas D Alessandro Nicolas M, Nisar Faria, Elsharkawy Hesham
The MetroHealth System, Case Western Reserve University School of Medicine, United States.
Department of Anesthesiology and Perioperative Services, MetroHealth System, 2500 MetroHealth Drive, Cleveland, OH, 44109, United States.
Interv Pain Med. 2025 Feb 6;4(1):100542. doi: 10.1016/j.inpm.2025.100542. eCollection 2025 Mar.
Chronic low back pain (CLBP) is a common and debilitating condition often difficult to diagnose, with entrapment of the superior cluneal nerves (SCN) being a overlooked cause. Cluneal neuralgia (CN) arises from injury to the SCN and can significantly impact patients' quality of life.
This case series aims to evaluate the effectiveness of the Micro Lead - SPRINT Peripheral Nerve Stimulation (PNS) System, (Cleveland, Ohio, USA) for treating cluneal neuralgia, utilizing both fluoroscopic and ultrasound guidance for accurate nerve localization.
A retrospective review was conducted on six nonconsecutive patients who underwent Micro Lead - SPRINT Peripheral Nerve Stimulation (PNS) System, (Cleveland, Ohio, USA) implantation for cluneal nerve entrapment at MetroHealth System between August 2021 and January 2024. Patient selection focused on individuals with cluneal neuralgia refractory to conservative treatments. Data collection included demographics, pain characteristics, opioid usage, and follow-up evaluations at 30, 60, 90 days, and 2 years post-procedure. Outcomes were assessed using the Numerical Rating Scale (NRS) for pain. Dividing the NRS score by the maximum score (10) and multiplying by 100 expresses pain intensity as a percentage.
Among the six nonconsecutive patients (83 % female, mean age 60 years), the mean pain score prior to implantation was 7.1. At follow-up, five patients reported over 50 % improvement in pain and functional status. Three patients with prior opioid use had varying outcomes regarding opioid consumption post-procedure.
The Micro Lead - SPRINT Peripheral Nerve Stimulation (PNS) System, (Cleveland, Ohio, USA) demonstrates promise as an effective treatment for cluneal neuralgia, leading to reductions in pain and improvements in daily living activities. Further studies are warranted to validate these findings.
慢性下腰痛(CLBP)是一种常见且使人衰弱的疾病,通常难以诊断,臀上皮神经(SCN)卡压是一个被忽视的病因。臀上皮神经痛(CN)由SCN损伤引起,会显著影响患者的生活质量。
本病例系列旨在评估微导线 - SPRINT外周神经刺激(PNS)系统(美国俄亥俄州克利夫兰市)治疗臀上皮神经痛的有效性,利用荧光镜和超声引导进行精确的神经定位。
对2021年8月至2024年1月期间在梅特罗健康系统接受微导线 - SPRINT外周神经刺激(PNS)系统(美国俄亥俄州克利夫兰市)植入术治疗臀上皮神经卡压的6例非连续患者进行回顾性研究。患者选择侧重于对保守治疗无效的臀上皮神经痛患者。数据收集包括人口统计学资料、疼痛特征、阿片类药物使用情况以及术后30天、60天、90天和2年的随访评估。使用数字评分量表(NRS)评估疼痛结果。将NRS评分除以最高分(10)再乘以100,以百分比表示疼痛强度。
在这6例非连续患者中(83%为女性,平均年龄60岁),植入前的平均疼痛评分为7.1。随访时,5例患者报告疼痛和功能状态改善超过50%。3例术前使用阿片类药物的患者术后阿片类药物使用情况有不同结果。
微导线 - SPRINT外周神经刺激(PNS)系统(美国俄亥俄州克利夫兰市)显示出作为臀上皮神经痛有效治疗方法的前景,可减轻疼痛并改善日常生活活动。需要进一步研究来验证这些发现。